Literature DB >> 28363489

Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Carol Durno1, C Richard Boland2, Shlomi Cohen3, Jason A Dominitz4, Frank M Giardiello5, David A Johnson6, Tonya Kaltenbach7, T R Levin8, David Lieberman9, Douglas J Robertson10, Douglas K Rex11.   

Abstract

The US Multi-Society Task Force on Colorectal Cancer, with invited experts, developed a consensus statement and recommendations to assist health care providers with appropriate management of patients with biallelic mismatch repair deficiency (BMMRD) syndrome, also called constitutional mismatch repair deficiency syndrome. This position paper outlines what is known about BMMRD, the unique genetic and clinical aspects of the disease, and reviews the current management approaches to this disorder. This article represents a starting point from which diagnostic and management decisions can undergo rigorous testing for efficacy. There is a lack of strong evidence and a requirement for further research. Nevertheless, providers need direction on how to recognize and care for BMMRD patients today. In addition to identifying areas of research, this article provides guidance for surveillance and management. The major challenge is that BMMRD is rare, limiting the ability to accumulate unbiased data and develop controlled prospective trials. The formation of effective international consortia that collaborate and share data is proposed to accelerate our understanding of this disease.
Copyright © 2017 AGA Institute, The American College of Gastroenterology, the American Society for Gastrointestinal Endoscopy, and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BMMRD; Biallelic Mismatch Repair Deficiency; CMMRD; Cancer; Childhood Cancer; Colorectal Cancer; Constitutional Mismatch Repair Deficiency; DNA Mismatch Repair; Lynch Syndrome

Mesh:

Year:  2017        PMID: 28363489     DOI: 10.1053/j.gastro.2017.02.011

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome.

Authors:  A Kerpel; M Yalon; M Soudack; J Chiang; A Gajjar; K E Nichols; Z Patay; S Shrot; C Hoffmann
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-30       Impact factor: 3.825

2.  Diagnostic challenges in a child with early onset desmoplastic medulloblastoma and homozygous variants in MSH2 and MSH6.

Authors:  Julia Taeubner; Katharina Wimmer; Martine Muleris; Olivier Lascols; Chrystelle Colas; Christine Fauth; Triantafyllia Brozou; Joerg Felsberg; Jasmin Riemer; Michael Gombert; Sebastian Ginzel; Jessica I Hoell; Arndt Borkhardt; Michaela Kuhlen
Journal:  Eur J Hum Genet       Date:  2018-01-04       Impact factor: 4.246

3.  Lynch syndrome-associated ultra-hypermutated pediatric glioblastoma mimicking a constitutional mismatch repair deficiency syndrome.

Authors:  Chen Yang; Frances Austin; Hope Richard; Michael Idowu; Vernell Williamson; Fernanda Sabato; Andrea Ferreira-Gonzalez; Scott A Turner
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-10-23

4.  Gastrointestinal Polyposis in Pediatric Patients.

Authors:  Suzanne P MacFarland; Kristin Zelley; Bryson W Katona; Benjamin J Wilkins; Garrett M Brodeur; Petar Mamula
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

Review 5.  Nervous system (NS) Tumors in Cancer Predisposition Syndromes.

Authors:  Prabhumallikarjun Patil; Bojana Borislavova Pencheva; Vinayak Mahesh Patil; Jason Fangusaro
Journal:  Neurotherapeutics       Date:  2022-09-02       Impact factor: 6.088

Review 6.  Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).

Authors:  Erika K S M Leenders; Harm Westdorp; Roger J Brüggemann; Jan Loeffen; Christian Kratz; John Burn; Nicoline Hoogerbrugge; Marjolijn C J Jongmans
Journal:  Eur J Hum Genet       Date:  2018-06-14       Impact factor: 4.246

Review 7.  Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.

Authors:  Patrick M Boland; Matthew B Yurgelun; C Richard Boland
Journal:  CA Cancer J Clin       Date:  2018-02-27       Impact factor: 508.702

8.  DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells.

Authors:  Jiil Chung; Yosef E Maruvka; Gad Getz; Uri Tabori; Sumedha Sudhaman; Jacalyn Kelly; Nicholas J Haradhvala; Vanessa Bianchi; Melissa Edwards; Victoria J Forster; Nuno M Nunes; Melissa A Galati; Martin Komosa; Shriya Deshmukh; Vanja Cabric; Scott Davidson; Matthew Zatzman; Nicholas Light; Reid Hayes; Ledia Brunga; Nathaniel D Anderson; Ben Ho; Karl P Hodel; Robert Siddaway; A Sorana Morrissy; Daniel C Bowers; Valérie Larouche; Annika Bronsema; Michael Osborn; Kristina A Cole; Enrico Opocher; Gary Mason; Gregory A Thomas; Ben George; David S Ziegler; Scott Lindhorst; Magimairajan Vanan; Michal Yalon-Oren; Alyssa T Reddy; Maura Massimino; Patrick Tomboc; An Van Damme; Alexander Lossos; Carol Durno; Melyssa Aronson; Daniel A Morgenstern; Eric Bouffet; Annie Huang; Michael D Taylor; Anita Villani; David Malkin; Cynthia E Hawkins; Zachary F Pursell; Adam Shlien; Thomas A Kunkel
Journal:  Cancer Discov       Date:  2020-12-18       Impact factor: 39.397

9.  Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.

Authors:  Rebekah Rittberg; Craig Harlos; Heidi Rothenmund; Anirban Das; Uri Tabori; Namita Sinha; Harminder Singh; Bernie Chodirker; Christina A Kim
Journal:  Curr Oncol       Date:  2021-02-01       Impact factor: 3.677

10.  Mutational cascades in cancer.

Authors:  Clement Richard Boland; Matthew B Yurgelun
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.